{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:00:47Z","timestamp":1791291647734,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1053\/j.seminhematol.2013.03.023","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T10:57:11Z","timestamp":1370948231000},"page":"175-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Animal Models of Hemophilia and Related Bleeding Disorders"],"prefix":"10.1053","volume":"50","author":[{"given":"Jay N.","family":"Lozier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2013.03.023_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1084\/jem.90.2.97","article-title":"Canine hemophilia: observations on the course, the clotting anomaly, and the effects of blood transfusion","volume":"90","author":"Graham","year":"1949","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1126\/science.111.2896.723","article-title":"Hemophilia in the female dog","volume":"111","author":"Brinkhous","year":"1950","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-0038-1661450","article-title":"Evaluation of the cuticle bleeding time in canine haemophilia A","volume":"55","author":"Pijnappels","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib4","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1182\/blood-2009-05-220327","article-title":"Recombinant canine B-domain deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model","volume":"114","author":"Sabatino","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib5","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1073\/pnas.192219599","article-title":"The Chapel Hill hemophilia A dog colony exhibits an inversion of the factor VIII gene","volume":"99","author":"Lozier","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood.V60.3.727.727","article-title":"A canine model of hemophilic (factor VIII:C deficiency) bleeding","volume":"60","author":"Giles","year":"1982","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1055\/s-0037-1613063","article-title":"Aberrant splicing and premature termination of transcription of the FVIII gene as a cause of severe canine hemophilia A: similarities with the intron 22 inversion mutation in human hemophilia","volume":"87","author":"Hough","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0888-7543(90)90512-S","article-title":"A transcribed gene in an intron of the human factor VIII gene","volume":"7","author":"Levinson","year":"1990","journal-title":"Genomics"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1193-236","article-title":"Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A","volume":"5","author":"Lakich","year":"1993","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib10","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1182\/blood.V87.8.3255.bloodjournal8783255","article-title":"A novel DNA inversion causing severe hemophilia A","volume":"87","author":"Naylor","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0038-1651541","article-title":"The development of homologous (canine\/anti-canine) antibodies in dogs with haemophilia A (factor VIII deficiency): a ten-year longitudinal study","volume":"69","author":"Tinlin","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-0037-1614984","article-title":"The canine factor VIII cDNA and 5' flanking sequence","volume":"79","author":"Cameron","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib13","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa075760","article-title":"Inhibitors of factor VIII in black patients with hemophilia","volume":"360","author":"Viel","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5326\/15473317-32-1-25","article-title":"Hemophilia A in a German shorthaired pointer: clinical presentations and diagnosis","volume":"32","author":"Joseph","year":"1996","journal-title":"J Am Anim Hosp Assoc"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib15","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1073\/pnas.82.24.8752","article-title":"Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs","volume":"82","author":"Brinkhous","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.V72.1.335.bloodjournal721335","article-title":"In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency)","volume":"72","author":"Giles","year":"1988","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ilar.50.2.144","article-title":"Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von Willebrand disease, and factor VII deficiency","volume":"50","author":"Nichols","year":"2009","journal-title":"ILAR J"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib18","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1365-2516.2011.02580.x","article-title":"Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs","volume":"17","author":"Karpf","year":"2011","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1182\/blood-2007-07-098913","article-title":"Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A","volume":"111","author":"Prasad","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib20","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2516.2012.02896.x","article-title":"Pharmacokinetics and pharmacodynamics of turoctocog alfa and N8-GP in haemophilia A dogs","volume":"18","author":"Agers\u00f8","year":"2012","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib21","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1182\/blood-2011-08-367813","article-title":"Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs","volume":"119","author":"Dumont","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib22","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1073\/pnas.86.4.1382","article-title":"Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease","volume":"86","author":"Brinkhous","year":"1989","journal-title":"I. Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib23","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1365-2516.2011.02536.x","article-title":"Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dog","volume":"17","author":"Knudsen","year":"2011","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2141.2010.08432.x","article-title":"Intravascular inhibition of factor VIIa and the analogue NN1731 by antithrombin","volume":"152","author":"Petersen","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2003-05-1426","article-title":"Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A","volume":"103","author":"Brown","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib26","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1073\/pnas.0409249102","article-title":"Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy","volume":"102","author":"Xu","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood-2005-12-5115","article-title":"Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs","volume":"108","author":"Jiang","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib28","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1538-7836.2006.01901.x","article-title":"Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model","volume":"4","author":"McCormack","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/hum.2006.17.427","article-title":"Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice","volume":"17","author":"Sarkar","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib30","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1538-7836.2006.01964.x","article-title":"Toward gene therapy for hemophilia A with novel adenoviral vectors: successes and limitations in canine models","volume":"4","author":"Arruda","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib31","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood-2008-07-168377","article-title":"Successful treatment of canine hemophilia by continuous expression of canine FVIIa","volume":"113","author":"Margaritis","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.trsl.2008.12.009","article-title":"Blood outgrowth endothelial cell migration and trapping in vivo: a window into gene therapy","volume":"153","author":"Milbauer","year":"2009","journal-title":"Transl Res"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib33","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1182\/blood-2010-06-288001","article-title":"Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy","volume":"116","author":"Finn","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1055\/s-0038-1646328","article-title":"Inherited defect of blood clotting factor VIII (haemophilia A) in sheep","volume":"68","author":"Neuenschwander","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib35","first-page":"27","article-title":"Factor VIII in blood plasma of haemophilic sheep: analysis of clotting time-plasma dilution curves","volume":"24","author":"Neuenschwander","year":"1994","journal-title":"Haemostasis"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/oxfordjournals.jhered.a111503","article-title":"Carrier detection of ovine hemophilia A using an RFLP marker, and mapping of the factor VIII gene on the ovine X-chromosome","volume":"85","author":"Backfisch","year":"1994","journal-title":"J Hered"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1538-7836.2009.03697.x","article-title":"Clinical and molecular characterization of a re-established line of sheep exhibiting hemophilia A","volume":"8","author":"Porada","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib38","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.exphem.2011.09.001","article-title":"Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC","volume":"39","author":"Porada","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib40","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1182\/blood.V88.9.3446.bloodjournal8893446","article-title":"Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies","volume":"88","author":"Bi","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib41","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1111\/j.1538-7836.2010.04084.x","article-title":"Towards a standardization of the murine tail bleeding model","volume":"8","author":"Greene","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib42","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1182\/blood-2011-07-367680","article-title":"Role of bone marrow transplantation for correcting hemophilia A in mice","volume":"119","author":"Follenzi","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib43","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0888-7543(92)90170-W","article-title":"Sequence of the human factor VIII-associated gene is conserved in mouse","volume":"13","author":"Levinson","year":"1992","journal-title":"Genomics"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib44","first-page":"25","article-title":"Spontaneous coagulopathy in inbred WAG\/RijYcb rats","volume":"60","author":"Booth","year":"2010","journal-title":"Comp Med"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib45","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1111\/j.1538-7836.2010.03978.x","article-title":"WAG-F8m1Ycb Rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A","volume":"8","author":"Booth","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.1960.tb06241.x","article-title":"Canine haemophilia B (Christmas disease)","volume":"6","author":"Mustard","year":"1960","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib47","doi-asserted-by":"crossref","first-page":"10095","DOI":"10.1073\/pnas.86.24.10095","article-title":"Canine hemophilia B resulting from a point mutation with unusual consequences","volume":"86","author":"Evans","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib48","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood.V88.9.3451.bloodjournal8893451","article-title":"A deletion mutation causes hemophilia B in Lhasa Apso dogs","volume":"88","author":"Mauser","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/mthe.2001.0442","article-title":"Muscle-directed gene transfer and transient immune suppression result in sustained and partial correction of canine hemophilia B caused by a null mutation","volume":"4","author":"Herzog","year":"2001","journal-title":"Mol Ther"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib50","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2460\/javma.1997.211.11.1418","article-title":"Complete deletion of factor IX gene and inhibition of factor IX activity in a Labrador retriever with hemophilia B","volume":"211","author":"Brooks","year":"1997","journal-title":"J Am Vet Med Assoc"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib51","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood.V90.10.3962","article-title":"A coagulation factor IX-deficient mouse model for human hemophilia B","volume":"90","author":"Lin","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib52","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.94.21.11563","article-title":"A factor IX-deficient mouse model for hemophilia B gene therapy","volume":"94","author":"Wang","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood.V92.1.168.413k06_168_174","article-title":"Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice","volume":"92","author":"Kundu","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib54","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1182\/blood-2004-01-0138","article-title":"Creation of a mouse expressing defective human factor IX","volume":"104","author":"Jin","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib55","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/j.1538-7836.2009.03545.x","article-title":"Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV","volume":"7","author":"Gui","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib56","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.gt.3302881","article-title":"Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant mice","volume":"14","author":"Zhang","year":"2007","journal-title":"Gene Ther"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib57","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2004-03-1126","article-title":"Mapping of genes that control the antibody response to human factor IX in mice","volume":"105","author":"Lozier","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib58","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.94.11.5804","article-title":"Stable gene transfer and expression of human FIX following intramuscular injection of recombinant AAV","volume":"94","author":"Herzog","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/4743","article-title":"Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector","volume":"5","author":"Herzog","year":"1999","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib60","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood.V99.8.2670","article-title":"Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy","volume":"99","author":"Mount","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/4751","article-title":"Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors","volume":"5","author":"Snyder","year":"1999","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib62","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/mthe.2000.0031","article-title":"Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver","volume":"1","author":"Wang","year":"2000","journal-title":"Mol Ther"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib63","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2005-10-4035","article-title":"Self complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver","volume":"107","author":"Nathwani","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib64","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2012-06-440123","article-title":"The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene","volume":"120","author":"Finn","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib65","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1182\/blood-2012-05-432591","article-title":"Hyper-functional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice","volume":"120","author":"Cantore","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib66","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","article-title":"AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B","volume":"101","author":"Manno","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib67","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib68","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib69","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood.V88.8.2939.bloodjournal8882939","article-title":"Shear-dependent change in the three dimensional structur of human von Willebrand factor","volume":"88","author":"Siedlecki","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib70","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/01.RES.0000267878.97021.ab","article-title":"Adhesion mechanisms in platelet function","volume":"100","author":"Ruggeri","year":"2007","journal-title":"Circulation Res"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0092-8674(00)80983-6","article-title":"Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor","volume":"84","author":"Savage","year":"1996","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, The National Heart, Lung, and Blood Institute (NHLBI) expert panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2004-02-0464","article-title":"Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells","volume":"105","author":"Haberichter","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib74","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood.V81.10.2644.2644","article-title":"The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A","volume":"81","author":"Nichols","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib75","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1172\/JCI112560","article-title":"Transplantation of normal bone marrow into a pig with severe von Willebrand disease","volume":"78","author":"Bowie","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib76","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.ATV.7.1.47","article-title":"Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease","volume":"7","author":"Wu","year":"1987","journal-title":"Arteriosclerosis"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib77","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1073\/pnas.92.7.2455","article-title":"Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: Effect on arterial thrombosis in chimeras","volume":"92","author":"Nichols","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib78","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0006-291X(92)91769-M","article-title":"Comparison of the primary structure of the functional domains of human and porcine von Willebrand factor that mediate platelet adhesion","volume":"182","author":"Bahnak","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib79","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1182\/blood.V96.5.1808","article-title":"Von Willebrand factor storage and multimerization: 2 independent processes","volume":"96","author":"Haberichter","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib80","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1073\/pnas.75.9.4514","article-title":"Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor","volume":"75","author":"Read","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2516.1998.0040s3053.x","article-title":"Evaluation of recombinant human von Willebrand factor in a canine model of von Willebrand disease","volume":"4","author":"Schwarz","year":"1998","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib82","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood.V90.9.3555","article-title":"In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease","volume":"90","author":"Turecek","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib83","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood-2003-01-0290","article-title":"Comparative response of plasma VWF in dogs to upregulation of VWF mRNA by interleukin-11 versus Wiebel-Palade body release by desmopressin (DDAVP)","volume":"102","author":"Olsen","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib84","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1365-2516.2008.01827.x","article-title":"A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease","volume":"14","author":"Ragni","year":"2008","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib85","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1160\/TH11-04-0274","article-title":"Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia","volume":"106","author":"Ragni","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib86","doi-asserted-by":"crossref","unstructured":"Ragni MV, Novelli EM, Murshed A, Merricks EP, Kloos MT, Nichols TC. Phase II prospective open-label trial of recombinant interleukin-11 in desmopressin-unresponsive von Willebrand disease and mild or moderate haemophilia A. Thromb Haemost. 2013;109:248\u201354","DOI":"10.1160\/TH12-06-0447"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib87","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1182\/blood.V72.1.308.308","article-title":"Molecular genetic analysis of porcine von Willebrand disease: tight linkage to the von Willebrand factor locus","volume":"72","author":"Bahou","year":"1988","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib88","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1182\/blood.V76.11.2258.2258","article-title":"The RIIIS\/J inbred mouse strain as a model for von Willebrand disease","volume":"76","author":"Sweeney","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib89","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1182\/blood.V83.11.3225.3225","article-title":"von Willebrand disease in the RIIIS\/J mouse is caused by a defect outside of the von Willebrand factor gene","volume":"83","author":"Nichols","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib90","doi-asserted-by":"crossref","first-page":"15352","DOI":"10.1073\/pnas.93.26.15352","article-title":"A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11","volume":"93","author":"Mohlke","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)80964-2","article-title":"Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase","volume":"96","author":"Mohlke","year":"1999","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib92","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"Denis","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib93","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1073\/pnas.061307098","article-title":"Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice","volume":"98","author":"Denis","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.023_bib94","first-page":"1471","article-title":"Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree","volume":"139","author":"Gebrane-Younes","year":"1991","journal-title":"Am J Pathol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196313000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196313000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:21:38Z","timestamp":1758522098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196313000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0037196313000474"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2013.03.023","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal Models of Hemophilia and Related Bleeding Disorders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2013.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}